BiomX Inc. is a microbiome company that develops natural and engineered phage technologies to combat harmful bacteria. They target various skin and chronic disease bacteria such as IBD, PSC, CF, atopic dermatitis, and CRC. They are developing BX004, BX005, and BX003, each having its own clinical trial phases, to combat specific bacterial targets.